title: Second allogeneic hematopoietic stem cell transplantation in hematologic malignancies in children: long-term results of a multicenter study of the Spanish Working Party for Bone Marrow Transplantation in Children (GETMON).
abstract: Twenty-four children with acute leukemia (21) or chronic myeloid leukemia (3) who relapsed after a first hematopoietic stem cell transplantation (HSCT) underwent a second allogeneic HSCT. Sixteen patients died from relapse or transplant related causes and 8 are alive and disease-free with a probability of event-free survival at 5 years of 32%. These results show that this procedure offers a chance to a subset of these patients.
authors.forename: Arturo
authors.initials: A
authors.lastname: Muñoz
authors.forename: Isabel
authors.initials: I
authors.lastname: Badell
authors.forename: Teresa
authors.initials: T
authors.lastname: Olivé
authors.forename: Amparo
authors.initials: A
authors.lastname: Verdeguer
authors.forename: Pedro
authors.initials: P
authors.lastname: Gómez
authors.forename: Encarna
authors.initials: E
authors.lastname: Bureo
mesh_terms: D000293:Adolescent; D002648:Child; D002669:Child Welfare; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000401:mortality*; D006801:Humans; D007938:Leukemia / Q000401:mortality / Q000628:therapy*; D008297:Male; D012008:Recurrence; D013030:Spain / Q000453:epidemiology; D015996:Survival Rate; D014184:Transplantation, Homologous / Q000009:adverse effects / Q000276:immunology / Q000401:mortality